BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
Heise, Tim, Meiffren, Grégory, Alluis, Bertrand, Seroussi, Cyril, Ranson, Aymeric, Arrubla, Jorge, Correia, José, Gaudier, Martin, Soula, Olivier, Soula, Rémi, DeVries, J. Hans, Klein, Oliver, Bode, Bruce
Published in Diabetes, obesity & metabolism (01.04.2019)
Published in Diabetes, obesity & metabolism (01.04.2019)
Get full text
Journal Article
CAD-19 - L’insuline ultra-rapide BioChaperone® Lispro améliore le contrôle glycémique postprandial par rapport à Humalog® chez des sujets diabétiques de type 1
Andersen, Grit, Meiffren, Gregory, Alluis, Bertrand, Ranson, Aymeric, Soula, Remi, Gaudier, Martin, Soula, Olivier, Kazda, Christof, Heise, Tim, Bruce, Simon
Published in Diabetes & metabolism (01.03.2017)
Published in Diabetes & metabolism (01.03.2017)
Get full text
Journal Article
L’insuline ultra-rapide BioChaperone ® Lispro améliore le contrôle glycémique postprandial par rapport à Humalog ® chez des sujets diabétiques de type 1
Andersen, Grit, Meiffren, Gregory, Alluis, Bertrand, Ranson, Aymeric, Soula, Remi, Gaudier, Martin, Soula, Olivier, Kazda, Christof, Heise, Tim, Bruce, Simon
Published in Diabetes & metabolism (01.03.2017)
Published in Diabetes & metabolism (01.03.2017)
Get full text
Journal Article
2008-P: BioChaperone Glucagon Exenatide (BC Glu Exe), a Stable Combination of Glucagon (Glu) and Exenatide (Exe) Achieved Larger Body Weight (BW) Loss than Exe Alone in DIO Mice
GAUDIER, MARTIN, HAKIM, SANA, MÉGRET, CLAIRE, BEZAGU, MARINE, FRANCOIS-HEUDE, MARC, REGAIRAZ, ANNE, MEIFFREN, GRÉGORY, SOULA, RÉMI, SOULA, OLIVIER
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
BioChaperone Technology Enables the Development of Pramlintide-Prandial Insulin Combinations
MEIFFREN, GRÉGORY, GEISSLER, ALEXANDRE, MEYER, YVES, RANSON, AYMERIC, FORTIER, CHARLES, SOULA, OLIVIER, SOULA, RÉMI, ALLUIS, BERTRAND, CHARVET, RICHARD
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
150-OR: BioChaperone Pramlintide Insulin (BCPramIns), a New Co-Formulation of Pramlintide (PRAM) and Human Insulin (INS), Improves Postprandial Blood Glucose (BG) vs. Both Separate Injections of PRAM+INS and Insulin Lispro (LIS) in Subjects with T1D
MEIFFREN, GRÉGORY, SEROUSSI, CYRIL, RANSON, AYMERIC, CHARVET, RICHARD, GAUDIER, MARTIN, ANDERSEN, GRIT, ZIJLSTRA, ERIC, DEVRIES, J. HANS, HEISE, TIM, SOULA, RÉMI, SOULA, OLIVIER
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
The Ultra-rapid Insulin (URI) BioChaperone Lispro (BCLIS) Shows Favorable Pharmacodynamics (PD) and Pharmacokinetics (PK) vs. Faster Aspart (FIA) and Insulin Aspart (ASP) in Insulin Pumps (CSII)
BODE, BRUCE W., KLEIN, OLIVER, SEROUSSI, CYRIL, RANSON, AYMERIC, ARRUBLA, JORGE, CORREIA, JOSÉ, GAUDIER, MARTIN, SOULA, OLIVIER, SOULA, RÉMI, ALLUIS, BERTRAND, MEIFFREN, GRÉGORY, GLEZER, STANISLAV, HEISE, TIM
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article